Ordinary Index Rebalancing in the Solactive China Biotech Innovation Index | November 2020

In the ordinary rebalance the following composition will be implemented effective open 16.11.2020:

3SBIO INC
ANHUI ANKE BIOTECHNOLOGY G-A
ASCENTAGE PHARMA GROUP INTERNATIONAL
BEIGENE LTD-ADR
BEIJING SL PHARMACEUTICAL -A
BEIJING TIANTAN BIOLOGICAL-A
BERRY GENOMICS CO LTD-A
BGI GENOMICS CO LTD-A
CHANGCHUN HIGH & NEW TECH-A
CHINA BIOLOGIC PRODUCTS HOLD
DA AN GENE CO LTD SUN YAT-A
FUJIAN ANJOY FOODS CO LTD
FUJIAN AONONG BIOLOGICAL T-A
GENSCRIPT BIOTECH CORP
GETEIN BIOTECH INC-A
HUALAN BIOLOGICAL ENGINEER-A
JINYU BIO-TECHNOLOGY CO LT-A
JOINN LABORATORIES CHINA CO LTD
PHARMABLOCK SCIENCES NANJI-A
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD
SHANGHAI RAAS BLOOD PRODUC-A
SHENZHEN KANGTAI BIOLOGICA-A
SHENZHEN NEPTUNUS BIOENG-A
SHENZHEN WEIGUANG BIOLOGIC-A
SICHUAN KELUN PHARMACEUTIC-A
SINO BIOPHARMACEUTICAL LTD ORD
VIVA BIOTECH HOLDINGS
WALVAX BIOTECHNOLOGY CO-A
WUXI BIOLOGICS CAYMAN INC
ZAI LAB LTD
ZHEJIANG WOLWO BIO-PHARMAC-A